FDA Adverse Event Injury Summary report: N

ONE TOUCH ULTRASMART METER

MDR report key: 1358163 · Received April 7, 2009

Report

Report Number
2939301-2009-02228
Event Type
Injury
Date Received
April 7, 2009
Date of Event
March 28, 2009
Report Date
March 28, 2009
Manufacturer
LIFESCAN, INC.
Product Code
NBW
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
LAY USER/PATIENT

Narratives

Additional Manufacturer Narrative · 1

LIFESCAN (LFS) HAS REQUESTED RETURN OF THE SUBJECT PRODUCT(S) FOR EVALUATION. IF THE PRODUCT(S) ARE RETURNED, LFS WILL EVALUATE IT/THEM AND INFORM FDA OF PRODUCT(S) THAT DO NOT PASS INSPECTION IN A SUPPLEMENTAL REPORT.

Description of Event or Problem · 1

IN 2009, THE LAY-USER/PT CONTACTED LIFESCAN ALLEGING THAT A ONE TOUCH ULTRASMART METER READ INACCURATELY HIGH. THE PT TREATS HER DIABETES WITH GLARGINE (LANTUS INSULIN) AND METFORMIN. THE PT INDICATED THAT THE ALLEGED METER ISSUE STARTED TWO DAYS PRIOR, AT 1:30 AM. THE PT REPORTED METER READINGS OF "241, 197, AND 137 MG/DL" BUT IT IS NOT KNOWN WHAT DATES/TIMES THE REPORTED RESULTS WERE OBTAINED. ON ORIGINAL DATE, AT 1:20 AM, THE PT'S BLOOD GLUCOSE WAS TESTED ON AN UNIDENTIFIED DEVICE AND A RESULT OF "170 MG/DL" WAS OBTAINED. AT 1:30 AM, THE PT CALLED A NURSE. THE NURSE ADVISED THE PT TO CALL HER DOCTOR AND TO ALSO TAKE A "GLUCOSE TABLET." IT IS NOT CLEAR IF THE PT WAS INSTRUCTED TO TAKE A TABLET TO RAISE HER BLOOD GLUCOSE. THE PT DENIED HAVING ANY SYMPTOMS OF HIGH/LOW BLOOD GLUCOSE DURING THE TIME OF CONCERN. IT WOULD HAVE BEEN HELPFUL TO KNOW THE FOLLOWING INFO: THE PATIENT'S TESTING FREQUENCY, WHEN THE REPORTED RESULTS WERE OBTAINED, WHAT DEVICE WAS USED TO OBTAIN THE READING OF "170 MG/DL," AND WHAT TYPE OF "GLUCOSE TABLET" THE PT WAS ADVISED TO TAKE. IN ADDITION, IT WOULD HAVE BEEN HELPFUL TO KNOW WHAT ACTIONS THE PT TOOK BEFORE CALLING THE NURSE , WHAT THE PT'S DOCTOR ADVISED HER TO DO, WHAT ACTIONS THE PT TOOK IN RESPONSE TO THE ALLEGED METER ISSUE, AND WHY THE PT WAS ADVISED TO TAKE THE GLUCOSE TABLET. THE PT WAS USING A CORRECT TECHNIQUE FOR TESTING WITH THE REPORTED METER. THE PT WAS OBTAINING BLOOD SAMPLES FROM HER FINGERS AND CLEANING THE PUNCTURE SITES CORRECTLY. THE METER, TEST STRIPS, AND CONTROL SOLUTION WERE REPLACED. BASED ON THE INFO PROVIDED, THIS COMPLAINT IS BEING REPORTED DUE TO THE FOLLOWING CONCLUSION: THE PT CLAIMED THAT SHE WAS ADVISED BY A NURSE TO TAKE A "GLUCOSE TABLET" AFTER THE METER STARTED READING INACCURATELY HIGH.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ONE TOUCH ULTRASMART METER GLUCOSE MONITORING SYS/KIT NBW LIFESCAN, INC. NA 2882786

Patients

Seq Age Sex Outcome Treatment
1 58 YR Life Threatening| R